Defibrillators devices are used to restore a normal heartbeat by sending an electric pulse or shock to the heart, also known as Automated External Defibrillator (AED), Implantable Cardioverter Defibrillator (ICD), and Wearable Cardioverter Defibrillator (WCD). This device is used to prevent or correct an arrhythmia, an uneven heartbeat, which is too slow or too fast. Furthermore, defibrillators can also restore the heart’s beating if the heart suddenly stops.


Worldwide, different types of defibrillators work in different ways. Say for instance, (AEDs) automated external defibrillators can be seen in many public places to rescue the lives of people who have sudden cardiac arrest. Even untrained people or bystanders can use these devices in an emergency. Defibrillators are immensely useful in reviving sudden cardiac arrest; this further pushed for the demand for defibrillators in the pandemic situation. Most probably, its timely supportive regulation and rising demand for adoption will see lucrative growth in this market in upcoming years. According to Renub Research, the Global Defibrillators Market will be US$ 18.01 Billion by 2027.


Worldwide Defibrillators Market was valued at US$ 12.87 Billion in 2021

The driving force towards global Defibrillators market growth are, awareness about the importance of good cardiac health, surging technology advancement across the globe, cases of cardiac disorders , and legislative reforms. Nevertheless, lack in advanced healthcare infrastructure, high cost, the weak reimbursement policies hinder the growth of the defibrillators market worldwide.


COVID-19 Impact on Medical Defibrillators Market

COVID?19 can affect the cardiovascular system, resulting in myocardial injury, arrhythmias, intravascular thrombosis, and sudden cardiac death. Initial reports have recommended a temporary association between COVID?19 activity and cardiac arrests in the community and within in?hospital settings. Life-threatening arrhythmias have been variably reported among patients hospitalized for COVID-19 infection. Sudden cardiac arrest (SCA) in COVID-19 patients is an alarming concern for clinicians. Defibrillator shock episodes has risen during the higher COVID?19 activity. Read the complete Defibrillators Market performance in COVID-19 times.


American Heart Association on Defibrillators

American Heart Association stated that about 20,000 lives are saved due to defibrillators’ availability every year and suggested that Public Access Defibrillators (PADs) must be available in the residential apartments, transportation centers, and public holdings.


Worldwide Defibrillators Industry will grow at a CAGR of 5.76% during 2021-2027

By Product type, we have categorized the global defibrillator market into the Implantable Cardioverter Defibrillator and External Defibrillator market. In this the market of External Defibrillator will grow at a great pace during the forecast period. External defibrillators are life-saving devices used to deliver a defibrillating shock to diagnose and restore heart rhythms in an unexpected cardiac arrest. Apart from that, the market of Implantable Cardioverter Defibrillator will also flourish during 2020-2027.


North America has the Lion Share of the Global Defibrillator Market

This report further segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East& Africa based on region. Upon which North America has the lion share of the global defibrillator market. Likewise, Asia-Pacific countries like China and India have a huge population base and at the same time, these countries offer immense opportunities to the market players and are expected to be the fastest-growing region during the forecast period.


Renub Research new report "Global Defibrillators Market by Product type {(Implantable Cardioverter Defibrillator, External Defibrillator), Implantable Cardioverter Defibrillator (Transvenous Implantable Cardioverter Defibrillators (T-ICDs), Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs), others), Transvenous Implantable Cardioverter Defibrillators (Single-Chamber Implantable Cardioverter Defibrillators, Dual-Chamber Implantable Cardioverter Defibrillators, Biventricular Implantable Cardioverter Defibrillators /Cardiac Resynchronization Therapy Defibrillators (CRT-Ds)), External Defibrillator (Automated External Defibrillators, Advanced Life Support Defibrillators, Wearable Cardioverter Defibrillators)}, End Users (Hospital, Prehospital, Public Access Market, Alternate Care Market, Home Healthcare), Regions (North America, Europe, Asia-Pacifics, Latin America, Middle East & Africa), Company (Medtronic Plc, Boston Scientific Corporation, Philips Healthcare, Nihon Kohden Corporation, Asahi Kasei Corporation)" provides comprehensive details on Global Defibrillators Market.


Product Type – Market breakup from 2 viewpoints

1. Implantable Cardioverter Defibrillator
2. External Defibrillator


Implantable Cardioverter Defibrillator –Market breakup from 3 viewpoints

1. Transvenous Implantable Cardioverter Defibrillators (T-ICDs)
2. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)
3. Others


Transvenous Implantable Cardioverter Defibrillators (T-ICDs) - Market breakup from 3 viewpoints

1. Single-Chamber Implantable Cardioverter Defibrillators
2. Dual-Chamber Implantable Cardioverter Defibrillators
3. Biventricular Implantable Cardioverter Defibrillators /Cardiac Resynchronization Therapy Defibrillators (CRT-Ds)


External Defibrillators – Market breakup from 3 viewpoints

1. Automated External Defibrillators
2. Advanced Life Support Defibrillators
3. Wearable Cardioverter Defibrillators


End Users – Market breakup from 5 viewpoints

1. Hospital
2. Prehospital
3. Public Access Market
4. Alternate Care Market
5. Home Healthcare


By Region – Market breakup from 5 viewpoints

1. North America
2. Europe
3. Asia Pacific
4. Latin America
5. Middle East and Africa


All companies have been covered from 3 viewpoints

  • Overview
  • Recent Development & Strategies
  • Financial Insights




Company Analysis

1. Medtronic Plc
2. Boston Scientific Corporation
3. Philips Healthcare
4. Nihon Kohden Corporation
5. Asahi Kasei Corporation